|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G01N 33/574 |
| (11) | Patento numeris | 2601529 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11749629.9 |
| Europos patento paraiškos padavimo data | 2011-08-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-06-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-12-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/046799 |
| Data | 2011-08-05 |
| (87) | Numeris | WO 2012/019125 |
| Data | 2012-02-09 |
| (30) | Numeris | Data | Šalis |
| 201161443955 P | 2011-02-17 | US | |
| 371537 P | 2010-08-06 | US |
| (72) |
GILDERSLEEVE, Jeffrey, US
CAMPBELL, Christopher, US
OYELARAN, Oyindasola, US
GULLEY, James, US
SCHLOM, Jeffrey, US
|
| (73) |
The United States of America, as represented by The Secretary, Department of Health and Human Services,
Office of Technology Transfer National Institutes of Health 6011 Executive Boulevard Suite 325 MSC 7660, Bethesda, Maryland 20892-7660,
US
|
| (54) | BIOMARKERS FOR PREDICTING RESPONSE TO A CANCER VACCINE |
| BIOMARKERS FOR PREDICTING RESPONSE TO A CANCER VACCINE |